# US 2019/0376024 A1 · Microgels and microtissues for use in tissue engineering

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0376024 A1
- Document ID: US20190376024A1
- Status: Published application
- Kind: A1
- Application number: 16/358,160
- Filed: 2019-03-19
- Published: 2019-12-12
- Earliest claimed: 2011-05-11
- Assignees: Massachusetts Institute of Technology
- Applicants: Massachusetts Institute of Technology
- Inventors: Sangeeta N. BHATIA; Cheri Y. LI
- Web page: https://patentgrep.com/patent/US20190376024A1

## CPC

- C12N 5/0012: {Cell encapsulation}
- C12N 5/0062: {General methods for three-dimensional culture}
- C12N 5/0671: {Three-dimensional culture, tissue culture or organ culture; Encapsulated cells}
- C12Q 1/02: involving viable microorganisms
- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12N 2513/00: 3D culture
- C12N 2531/00: Microcarriers
- C12N 2533/30: Synthetic polymers
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

The present invention features microgels and microtissues for use in tissue engineering. Featured is a microencapsulation device for making microgels and/or microtissues via an emulsion technology. Also featured are methods of making higher ordered structures that mimic in vivo tissue structures. Methods of us are also featured.

## Claims

### Claim 1

A population of microtissues produced by a method comprising injecting into a channel of a microfluidic device a first input stream comprising a solution of cells and a second input stream comprising a polymerizable hydrogel solution to form a combined aqueous stream;
emulsifying the combined aqueous stream with an emulsion stream in a first region of the channel of the microfluidic device, to produce droplets comprising the cells in the polymerizable hydrogel,
mixing said droplets to disperse the cells in the polymerizable hydrogel in a second region of the channel comprising a serpentine section in the microfluidic device;
polymerizing the droplets comprising the cells dispersed in the polymerizable hydrogel to form the microtissues; and
collecting the microtissues from an outlet of the device,
such that the population of microtissues is made.

### Claim 2 (depends on 1)

The population of claim 1, wherein the hydrogel material is agarose, fibrin, or polyethylene hydrogel.

### Claim 3

A population of microtissues produced by a method comprising injecting into a channel of a microfluidic device a solution comprising pre-stabilized, micropatterned cell clusters and a polymerizable hydrogel solution, wherein the cell clusters comprise parenchymal cells and supporting nonparenchymal cells;
emulsifying the solution of cell clusters and polymerizable hydrogel with an emulsion stream in a channel of the microfluidic device, to produce droplets comprising the cells in the polymerizable hydrogel,
polymerizing the droplets comprising the cells dispersed in the polymerizable hydrogel to form the microtissues, wherein polymerizing occurs during transport of the droplets, wherein transport occurs continuously; and
collecting the microtissues from an outlet of the device, such that the population of microtis sues is made.

### Claim 4 (depends on 3)

The population of claim 3, wherein the cell clusters comprise primary hepatocytes and stromal cells, for example, fibroblasts.

### Claim 5 (depends on 3)

The population of claim 3, wherein the cell clusters comprise hepatocytes selected from the group consisting of progenitor-derived hepatocytes, ES-derived hepatocytes, and induced pluripotent stem cell-derived (iPS-derived) hepatocytes, and stromal cells, for example, fibroblasts.

### Claim 6 (depends on 3)

The population of claim 3, wherein the cell clusters comprise cancer cells and stromal cells, for example, fibroblasts.

### Claim 7 (depends on 1)

The population of claim 1, wherein the prepolymerized hydrogel is a photopolymerizable hydrogel, for example, polyethylene glycol (PEG) hydrogel.

### Claim 8 (depends on 1)

The population of claim 1, wherein the hydrogel is functionalized with one or more affinity biomolecules facilitating higher ordered assembly of the said microtissues.

### Claim 9 (depends on 8)

The population of claim 8, wherein the biomolecule is streptavidin, or a cell adhesive peptide, for example, the biomolecule is RGDS peptide.

### Claim 10 (depends on 3)

The population of claim 3, wherein the droplets or microtissues are about 50 to about 250 μM in diameter.

### Claim 11 (depends on 1)

The population of claim 1, wherein the droplets of microtissues are about 20 to about 150 μM in diameter.

### Claim 12 (depends on 1)

The population of claim 1, wherein the droplets comprise about 1 to about 50 cells.

### Claim 13 (depends on 1)

The population of claim 1, wherein each microtissue comprises about 2 to about 20 cells or wherein each microtissue comprises about 5 to about 10 cells.

### Claim 14 (depends on 1)

A method of making a construct, comprising assembling all or a portion of the population of microtissues of claim 1 into a higher ordered structure.

### Claim 15 (depends on 14)

The method of claim 14, wherein the microtissues comprise an encoding biomolecule or affinity ligand and a substrate is patterned with a templating biomolecule or ligand, such that when the substrate is contacted with the population of microtissues, the microtissues are assembled in the pattern of the substrate.

### Claim 16 (depends on 15)

The method of claim 15, wherein the encoding and templating biomolecules are complementary DNAs or complementary affinity ligands.

### Claim 17 (depends on 14)

The method of claim 14, wherein the microtissues are assembled by physical means.

### Claim 18 (depends on 15)

A construct produced by the method of claim 15.

### Claim 19 (depends on 18)

An assay system featuring the construct of claim 18.

### Claim 20 (depends on 19)

The assay system of claim 19, which is a metabolic assay system or a toxicology assay system.

### Claim 21 (depends on 20)

The assay system of claim 20, which is a screening assay system for anti-tumorogenic compounds.

### Claim 22

A microencapsulation device comprising one or more injection ports in contact with a microchannel comprised therein, said injection ports for introducing one or more aqueous solutions, a droplet generating nozzle into which said solutions flow, an emulsion stream in contact with said droplet generating nozzle, a mixer section for dispersing components of droplets, a polymerizing section, and an outlet.

### Claim 23

A microencapsulation device as depicted in FIG. 2.
